Free Webinar

The Science Behind the New Cannabinoids Coming to Market

About the Webinar

You might have heard a lot about TCH and CBD, but also coming to market will be CBDA, CBDV, CBC, CBG, and more! What do you need to know? Join Dr. Jamie Baumgartner, Director of Science and President of Panacea Life Sciences, a recognized expert in cannabinoids. He'll explain:

  • Why cannabinoids?

  • Regulatory issues

    USA and International regulatory landscape; INCI names

  • Dermal cannabinoid effects

    Including poly-pharmacology

  • What does the future hold?

  • About Dr. Baumgartner
    ​​​​​​​Jamie holds a Bachelor of Science in Biochemistry from the UC, Davis and a Ph.D. in Biochemistry from Washington State University. He has worked with over 700 biotechnology and pharmaceutical companies in drug discovery and development. 
    Since conducting initial testing of CBD and THC on various preclinical models of pain, Jamie has devoted his efforts to develop and characterizing industrial hemp-based products for people in need of alternative medications. Currently, Jamie is focused on building a researc platform to evaluate caannabidiol and other cannabinoids for biological effects, developing collaborations with research institutions, and working with various government agencies to educate and influece policy relating to industrial hemp.
    ​​​​​​​

  • Mònica Morales, IFSCC Secretary General

    Presenter

  • IFSCC Secretary General

    Presenter

  • , ,